M1023 Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

Short descriptor: Adl pt mj dep ds rs 6 phq<5

⚠ Terminated HCPCS Level II 2026
Terminated Code
M1023 was terminated as of 2020-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open M1023 in the app →

Look up M1023 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

M1023 is the HCPCS Level II code for Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Medical care
Effective Date
2021-01-01
Termination Date
2020-12-31
2026 Maintenance
No change this year

References

Cite This Page

Reference M1023 with the canonical source and edition:

M1023 — Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M1023

Canonical URL: https://icd10codingpro.com/hcpcs-codes/M1023

Related Codes in Section M

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial